View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Notification de participation par BNP Paribas Asset Management

Notification de participation par BNP Paribas Asset Management Communiqué de presse                                                                                                  Information réglementée Bruxelles, le 18 mars 2025 - 18h CET Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), BNP Paribas Asset Management Holding a envoyé récemment à Solvay la notification de transparence suivante indiquant avoir franchi le seuil de 3%. Voici un résumé de la notification: Date à laquelle le seuil a été franchi Droits de vote a...

 PRESS RELEASE

Participatiemelding van BNP Paribas Asset Management

Participatiemelding van BNP Paribas Asset Management Persbericht                                                                                                       Gereglementeerde informatie Brussel, 18 maart 2025 - 18u CET In overeenstemming met de Belgische transparantiewetgeving (Wet van 2 mei 2007) heeft BNP Paribas Asset Management Holding onlangs de volgende transparantiekennisgeving naar Solvay gestuurd om aan te geven dat ze de drempel van 3% heeft overschreden. Hier is een samenvatting van de beweging: Datum van drempeloverschrijding Stemrechten na de transactie A...

 PRESS RELEASE

Participation notification by BNP Paribas Asset Management

Participation notification by BNP Paribas Asset Management Press release                                                                                                           Regulated information Brussels, March 18, 2025, 18:00 CET In line with Belgian transparency legislation (Law of May 2, 2007), BNP Paribas Asset Management Holding recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%. Here is a summary of the notification: Date on which the threshold was crossed Voting rights after the transaction Equivalent finan...

Jacob Mekhael
  • Jacob Mekhael

Sequana Medical FIRST LOOK: Additional funding extends runway to YE25

Sequana announced that it has secured additional financing including a €4m convertible, and a facility agreement with GEM up to €20m, as well as amending the terms of the Kreos and PMV loans. The new cash provides funding to YE25, and gives the company breathing room to progress towards US commercialisation of the alfapump expected in 3Q25. We plan to incorporate this new financing in a future model update. BUY reiterated.

Jacob Mekhael ... (+2)
  • Jacob Mekhael
  • Wim Hoste
Wim Hoste
  • Wim Hoste

Solvay From gold to silver in soda ash

Solvay has lost its top spot in the global soda ash market following the acquisition of Genesis Alkali by WE Soda. Whilst soda ash prices continue to be impacted in 2025 by weak end markets, we still see a case for a gradual market tightening and increasing pricing power in the years ahead. Combined with continued savings deliveries, this translates into an adjusted EBITDA CAGR forecast of 5.5% for the period 2026-2028, after a presumed flat 2025. Solvay is a base chemicals group with a prudent ...

 PRESS RELEASE

Solvay: acquisition of own shares

Solvay: acquisition of own shares Press release  -  Regulated information  Brussels, March 13, 2025, 6:00pm CEST In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code of Companies and Associations, Solvay SA hereby confirms that, as announced on March 6, 2025, the Company recently acquired a total of 175,300 shares of the Company on Euronext Brussels, for the purpose of meeting any delivery obligations of Solvay shares arising from grants of its 2025 long-term incentive plans. Date of repurchase Number of shares Average pric...

 PRESS RELEASE

Solvay: acquisition d’actions propres

Solvay: acquisition d’actions propres Communiqué de presse  -  Information réglementée  Bruxelles, le 13 mars 2025 - 18h00 CEST Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 exécutant le Code belge des sociétés et des associations, Solvay SA confirme que, comme annoncé le 6 mars 2025, la Société a récemment acquis un total de 175 300 actions de la Société sur Euronext Brussels, dans le but de répondre à toute obligation de livraison d'actions Solvay découlant de l'octroi de ses plans d'intéressement à long terme 2025. Date d’achat Nombre d’actions Prix moyen pay...

 PRESS RELEASE

Solvay: verwerving van eigen aandelen

Solvay: verwerving van eigen aandelen Persbericht  -  Gereglementeerde informatie Brussel, 13 maart 2025 - 18u00 CEST In overeenstemming met artikel 8:4 van het Koninklijk Besluit van 29 april 2019 tot uitvoering van het Belgisch Wetboek van Vennootschappen en Verenigingen, maakt Solvay NV hierbij bekend dat de Vennootschap, zoals aangekondigd op 6 maart 2025, recentelijk in totaal 175 300 aandelen van de Vennootschap heeft verworven op Euronext Brussel, met de bedoeling te voldoen aan de eventuele leveringsverplichtingen van Solvay-aandelen die voortvloeien uit de toekenning van zijn...

Stefano Toffano
  • Stefano Toffano
Ahmed Ben Salem ... (+2)
  • Ahmed Ben Salem
  • Baptiste Lebacq
Ahmed Ben Salem ... (+2)
  • Ahmed Ben Salem
  • Baptiste Lebacq
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Air France-KLM: Surprising 4Q to the upside. CMB.TECH: A golden step into Golden Ocean? EVS: Evertz 3Q25 results. GBL: Boosting its liquidity profile. Gimv: Continued transaction spree post capital increase. Solvay: 4Q24 beat, 2025F guide in-line, reaffirmed 2028F target. Talabat: Completes InstaShop acquisition

Guy Sips ... (+8)
  • Guy Sips
  • Hilde Van Boxstael
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : ATEB BB, COMB BB, CPINV BB, EVS BB, GBLB BB, GIMB BB, ...

: ATEB BB, COMB BB, CPINV BB, EVS BB, GBLB BB, GIMB BB, IMMO BB, SIP BB, SOLB BB, VPK NA, DEME BB

Wim Hoste
  • Wim Hoste

Solvay FIRST LOOK: Solid 4Q24, good savings delivery, broad FY25 guida...

Solvay reported better than expected 4Q underlying EBITDA, up 2% organically to 256m, which was 9% better than our forecast and 8% above CSS. Solvay remains prudent on the outlook, guiding for a broad €1.0-1.1bn range, with both KBCS and CSS currently around the midpoint. Solvay is a base chemicals group with leading market and technology positions in the vast majority of its businesses. The company favours dividends over aggressive growth (c. 8% dividend yield) and operates with a solid balance...

 PRESS RELEASE

Solvay fourth quarter and full year 2024 results

Solvay fourth quarter and full year 2024 results Press release   Regulated information Solid EBITDA and free cash flow supported by cost savings acceleration Brussels, March 6, 2025, 7.00am CET Highlights “Essential for Generations”: Solvay’s ambition is to be a leader in Essential Chemistry. Despite challenging market conditions in 2024, we proved the resilience of our business and our strong execution, delivering solid results. This allows us to confirm our 2028 EBITDA mid-single digit annual growth target. Launch of the “For Generations” roadmap, defining the foundations of Sustai...

 PRESS RELEASE

Solvay : résultats du quatrième trimestre et de l’année 2024

Solvay : résultats du quatrième trimestre et de l’année 2024 Communiqué de presse   Information réglementée EBITDA et free cash flow solides, soutenus par l'accélération des réductions de coûts  Bruxelles, le 6 mars 2025 - 7h00 CET Faits marquants “Essential for Generations” : L'ambition de Solvay est d'être un leader dans la chimie essentielle. Malgré des conditions de marché difficiles en 2024, nous avons prouvé la résilience de nos activités et notre forte capacité d’exécution, en obtenant de solides résultats. Cela nous permet de confirmer notre objectif de croissance annuelle de...

 PRESS RELEASE

Solvay 2024 vierde kwartaal en jaarresultaten

Solvay 2024 vierde kwartaal en jaarresultaten Persbericht   Gereglementeerde informatie   Solide EBITDA en vrije kasstroom ondersteund door versnelde kostenbesparingen Brussel, 6 maart 2025, 7u00 CET Hoogtepunten Essential for Generations: Solvay heeft de ambitie een leider te zijn in essentiële chemie. Ondanks uitdagende marktomstandigheden in 2024 hebben we de veerkracht van ons bedrijf en onze sterke uitvoering bewezen, met solide resultaten. Hierdoor kunnen we onze EBITDA-doelstelling voor 2028 bevestigen, met een ‘mid-single digit’ jaarlijkse groei.Lancering van de “For Generat...

Hilde Van Boxstael ... (+3)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Wim Lewi
Jacob Mekhael
  • Jacob Mekhael

Sequana Medical Becoming a commercial stage medtech

With the alfapump FDA approval in liver ascites obtained in 4Q24, Sequana enters 2025 with the clear aim of building out its commercial organisation in the US. While the company's cash runway is until 1Q25, we believe the FDA approval could attract new investors into the stock, and US commercialisation is targeted for 2H25. We re-model Sequana taking into account the updated timelines, and estimate peak sales of approx. €240m for the alfapump in liver ascites in the US. This brings us to a new T...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch